125 related articles for article (PubMed ID: 38709240)
1. Novel Effective Medical Therapy for Acanthamoeba Keratitis.
Di Zazzo A; De Gregorio C; Coassin M
Eye Contact Lens; 2024 Jun; 50(6):279-281. PubMed ID: 38709240
[TBL] [Abstract][Full Text] [Related]
2. Successful medical treatment of Acanthamoeba keratitis.
Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
[TBL] [Abstract][Full Text] [Related]
3. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
[TBL] [Abstract][Full Text] [Related]
4. The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.
Dart JKG; Papa V; Rama P; Knutsson KA; Ahmad S; Hau S; Sanchez S; Franch A; Birattari F; Leon P; Fasolo A; Kominek EM; Jadczyk-Sorek K; Carley F; Hossain P; Minassian DC
Ophthalmology; 2024 Mar; 131(3):277-287. PubMed ID: 37802392
[TBL] [Abstract][Full Text] [Related]
5. Acanthamoeba Keratitis: Perspectives for Patients.
Bonini S; Di Zazzo A; Varacalli G; Coassin M
Curr Eye Res; 2021 Jun; 46(6):771-776. PubMed ID: 33151784
[No Abstract] [Full Text] [Related]
6. [Good outcome in Acanthamoeba keratitis].
Reichart-Peter S; Manousaridis K; Dirschmid H; Mennel S
Ophthalmologe; 2017 Jul; 114(7):653-655. PubMed ID: 27558689
[TBL] [Abstract][Full Text] [Related]
7. [Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
Vaquero Ruano M; Encinas Martín JL; Ramón Y Cajal S; Cajigal Morales C
Arch Soc Esp Oftalmol; 2002 May; 77(5):279-81. PubMed ID: 12023748
[TBL] [Abstract][Full Text] [Related]
8. [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
Donoso R; Mura JJ; López M
Rev Med Chil; 2002 Apr; 130(4):396-401. PubMed ID: 12090104
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Larkin DF; Kilvington S; Dart JK
Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide.
Varga JH; Wolf TC; Jensen HG; Parmley VC; Rowsey JJ
Am J Ophthalmol; 1993 Apr; 115(4):466-70. PubMed ID: 8470718
[TBL] [Abstract][Full Text] [Related]
11. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.
Hargrave SL; McCulley JP; Husseini Z
Ophthalmology; 1999 May; 106(5):952-7. PubMed ID: 10328395
[TBL] [Abstract][Full Text] [Related]
12. Painless Acanthamoeba Keratitis with Normal Vision.
Kwok PW; Kam KW; Jhanji V; Young AL
Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
[TBL] [Abstract][Full Text] [Related]
13. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
14. Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
Musayeva A; Riedl JC; Schuster AK; Wasielica-Poslednik J; Pfeiffer N; Gericke A
Cornea; 2020 Aug; 39(8):986-990. PubMed ID: 32243421
[TBL] [Abstract][Full Text] [Related]
15. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
[TBL] [Abstract][Full Text] [Related]
16. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
[TBL] [Abstract][Full Text] [Related]
17. Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.
Hassan F; Bhatti A; Desai R; Barua A
Cont Lens Anterior Eye; 2019 Oct; 42(5):506-511. PubMed ID: 31018907
[TBL] [Abstract][Full Text] [Related]
18. A case series of acanthamoeba keratitis in Singapore.
Cheng CL; Ling ML; Lim L
Singapore Med J; 2000 Nov; 41(11):550-3. PubMed ID: 11284615
[TBL] [Abstract][Full Text] [Related]
19. Acanthamoeba keratitis: risk factors and outcome.
Hay J; Seal DV
Br J Ophthalmol; 1996 Aug; 80(8):773-4. PubMed ID: 8949730
[No Abstract] [Full Text] [Related]
20. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
